Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
80.04
+4.22 (+5.57%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM
December 21, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
December 21, 2024
Via
The Motley Fool
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
December 17, 2024
From
DexCom, Inc.
Via
Business Wire
Peering Into DexCom's Recent Short Interest
December 16, 2024
Via
Benzinga
Key Takeaways From DexCom Analyst Ratings
December 09, 2024
Via
Benzinga
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
December 02, 2024
Via
The Motley Fool
Exploring the Growth Potential of NASDAQ:DXCM as It Nears a Breakout.
December 02, 2024
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
Via
Chartmill
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
November 11, 2024
Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via
Benzinga
2 Excellent Healthcare Stocks to Hold Through the Next Decade
November 28, 2024
Via
The Motley Fool
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
November 26, 2024
Via
The Motley Fool
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
November 24, 2024
Via
The Motley Fool
Dexcom and ŌURA Announce Strategic Partnership
November 19, 2024
From
DexCom, Inc.
Via
Business Wire
Analyst Expectations For DexCom's Future
October 25, 2024
Via
Benzinga
Large-Cap Stocks In Trouble - Sunday, Nov. 17
November 17, 2024
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.
Via
Talk Markets
Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom
November 14, 2024
Billionaire investor Chase Coleman's hedge fund, Tiger Global Management, filed its latest Form 13F on Thursday and disclosed its trading activity from the prior quarter.
Via
Benzinga
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
November 14, 2024
From
DexCom, Inc.
Via
Business Wire
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
October 25, 2024
Via
Benzinga
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
November 08, 2024
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.
Via
Investor's Business Daily
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
November 08, 2024
This medical device company is down but not out.
Via
The Motley Fool
Why DexCom Stock Flopped on Friday
October 25, 2024
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.
Via
The Motley Fool
Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
October 25, 2024
Stocks are finishing the week strong, but it's a pyrrhic victory, with two of the three major indexes still staring down sizable weekly losses.
Via
Talk Markets
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
October 25, 2024
The major indexes were mixed for the week.
Via
Investor's Business Daily
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
October 25, 2024
Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks.
Via
Benzinga
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
DexCom (DXCM) Q3 2024 Earnings Call Transcript
October 24, 2024
DXCM earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
DexCom Stock Drops After Q3 Results, Announces C-Suite Transition
October 24, 2024
DexCom reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 24, 2024
Via
Benzinga
Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash.
October 24, 2024
The company continues to expect 11% to 13% organic sales growth this year.
Via
Investor's Business Daily
Dexcom Reports Third Quarter 2024 Financial Results
October 24, 2024
From
DexCom, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.